(Q36062048)

11 August 2017

1 reference

title

Gatifloxacin: a review of its use in the treatment of bacterial infections in the US. (English)

1 reference

11 August 2017

3

Gillian M Keating

1 reference

11 August 2017

Susan J Keam

1

1 reference

11 August 2017

Katherine F Croom

series ordinal

2

1 reference

11 August 2017

publication date

1 January 2005

1 reference

11 August 2017

1 reference

11 August 2017

volume

65

1 reference

11 August 2017

issue

5

1 reference

11 August 2017

page(s)

695-724

1 reference

Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000-2001): report from the SENTRY Antimicrobial Surveillance Program

11 August 2017

cites work

1 reference

12 December 2020

Gatifloxacin, Gemifloxacin, and Moxifloxacin: The Role of 3 Newer Fluoroquinolones

1 reference

12 December 2020

Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose

1 reference

12 December 2020

Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens

1 reference

12 December 2020

IV-to-oral switch therapy for community-acquired pneumonia requiring hospitalization: focus on gatifloxacin

1 reference

12 December 2020

Community-based treatment of acute uncomplicated bacterial rhinosinusitis with gatifloxacin

1 reference

12 December 2020

In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms

1 reference

12 December 2020

In-vitro activity of gatifloxacin against Chlamydia trachomatis and Chlamydia pneumoniae

1 reference

12 December 2020

Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae

1 reference

12 December 2020

Gatifloxacin: a review of its use in the management of bacterial infections

1 reference

12 December 2020

Interchangeability of 400-mg intravenous and oral gatifloxacin in healthy adults.

1 reference

12 December 2020

Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin

1 reference

12 December 2020

Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000-01.

1 reference

12 December 2020

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

1 reference

12 December 2020

Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America).

1 reference

12 December 2020

Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus

1 reference

12 December 2020

Clinical pharmacodynamics of quinolones

1 reference

12 December 2020

Gatifloxacin phase IV surveillance trial (TeqCES study) utilizing 5000 primary care physician practices: report of pathogens isolated and susceptibility patterns in community-acquired respiratory tract infections

1 reference

12 December 2020

Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium

1 reference

12 December 2020

Use of pharmacodynamic end points in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis

1 reference

12 December 2020

Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise.

1 reference

12 December 2020

Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002

1 reference

12 December 2020

Contemporary in vitro synergy rates for aztreonam combined with newer fluoroquinolones and β-lactams tested against gram-negative bacilli

1 reference

12 December 2020

Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000)

1 reference

12 December 2020

Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents

1 reference

12 December 2020

Postantibiotic effects of gatifloxacin against gram-positive and -negative organisms.

1 reference

12 December 2020

Minimal interaction between gatifloxacin and oxycodone

1 reference

12 December 2020

Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy

1 reference

12 December 2020

In vitro antibacterial activity and pharmacodynamics of new quinolones

1 reference

12 December 2020

DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis

1 reference

12 December 2020

Bradycardic syncope in 2 patients who recently began gatifloxacin treatment

1 reference

12 December 2020

Mechanisms of resistance among respiratory tract pathogens

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans

1 reference

12 December 2020

The effect of pharmacokinetic/pharmacodynamic (PK/PD) parameters of gatifloxacin on its bactericidal activity and resistance selectivity against clinical isolates of Streptococcus pneumoniae

1 reference

12 December 2020

Comparative killing rates of gatifloxacin and ciprofloxacin against 14 clinical isolates: impact of bacterial strain and antibiotic concentration

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of fluoroquinolones

1 reference

12 December 2020

Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.

1 reference

12 December 2020

In vitro activities of telithromycin and 10 oral agents against aerobic and anaerobic pathogens isolated from antral puncture specimens from patients with sinusitis

1 reference

12 December 2020

Gatifloxacin in community-based treatment of acute respiratory tract infections in the elderly

1 reference

12 December 2020

Oral gatifloxacin in outpatient community-acquired pneumonia: results from TeqCES, a community-based, open-label, multicenter study

1 reference

12 December 2020

Principles of appropriate antibiotic use for acute sinusitis in adults

1 reference

12 December 2020

Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance

1 reference

12 December 2020

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

1 reference

12 December 2020

Inhibitory and bactericidal activities of gemifloxacin and other antimicrobials against Mycoplasma pneumoniae

1 reference

12 December 2020

Antianaerobic activity of a novel fluoroquinolone, WCK 771, compared to those of nine other agents

1 reference

12 December 2020

Safety and pharmacokinetics of a single oral dose of gatifloxacin in patients with moderate to severe hepatic impairment.

1 reference

12 December 2020

Fluoroquinolone-resistant Haemophilus influenzae: frequency of occurrence and analysis of confirmed strains in the SENTRY antimicrobial surveillance program (North and Latin America).

1 reference

12 December 2020

A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis

1 reference

12 December 2020

Expression of efflux pump gene pmrA in fluoroquinolone-resistant and -susceptible clinical isolates of Streptococcus pneumoniae

1 reference

12 December 2020

Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network

1 reference

12 December 2020

Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995.

1 reference

12 December 2020

The bactericidal activity of gatifloxacin in plasma and urine.

1 reference

12 December 2020

Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors

1 reference

12 December 2020

Increased antibiotic resistance in respiratory tract pathogens: PROTEKT US--an update

1 reference

12 December 2020

Medical management of acute bacterial sinusitis. Recommendations of a clinical advisory committee on pediatric and adult sinusitis.

1 reference

12 December 2020

The role of fluoroquinolones in skin and skin structure infections

1 reference

12 December 2020

Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.

1 reference

12 December 2020

Bactericidal activities of methoxyfluoroquinolones gatifloxacin and moxifloxacin against aerobic and anaerobic respiratory pathogens in serum

1 reference

12 December 2020

Molecular characterization of fluoroquinolone resistant Streptococcus pneumoniae clinical isolates obtained from across Canada

1 reference

12 December 2020

Efficacy and safety of gatifloxacin in elderly outpatients with community-acquired pneumonia

1 reference

12 December 2020

Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002

1 reference

12 December 2020

Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I--results from the SENTRY Antimicrobial Surveillance Program (North America, 1998).

1 reference

12 December 2020

Antimicrobial activity of gatifloxacin tested against Neisseria gonorrhoeae using three methods and a collection of fluoroquinolone-resistant strains

1 reference

12 December 2020

Single-dose gatifloxacin compared with ofloxacin for the treatment of uncomplicated gonorrhea: a randomized, double-blind, multicenter trial

1 reference

12 December 2020

Hypoglycemia and hyperglycemia associated with gatifloxacin use in elderly patients.

1 reference

12 December 2020

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

1 reference

12 December 2020

Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administrations of 400 milligrams to volunteers

1 reference

12 December 2020

Worldwide antimicrobial susceptibility patterns and pharmacodynamic comparisons of gatifloxacin and levofloxacin against Streptococcus pneumoniae: report from the Antimicrobial Resistance Rate Epidemiology Study Team

1 reference

12 December 2020

A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis

1 reference

12 December 2020

Randomised double-blind comparison of oral gatifloxacin and co-amoxiclav for acute exacerbation of chronic Bronchitis

1 reference

12 December 2020

Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study

1 reference

12 December 2020

Antibacterial susceptibility among Streptococcus pneumoniae isolated from paediatric and adult patients as part of the PROTEKT US study in 2001-2002.

1 reference

12 December 2020

Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000.

1 reference

12 December 2020

Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000).

1 reference

12 December 2020

In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002

1 reference

12 December 2020

Mechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureus

1 reference

12 December 2020

Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study

1 reference

12 December 2020

Age and gender effects on the pharmacokinetics of gatifloxacin.

1 reference

12 December 2020

Comparative assessment of prurifloxacin, sparfloxacin, gatifloxacin and levofloxacin in the rabbit model of proarrhythmia

1 reference

12 December 2020

Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections

1 reference

12 December 2020

Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates

1 reference

12 December 2020

Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG.

1 reference

12 December 2020

The role of PK/PD parameters to avoid selection and increase of resistance: mutant prevention concentration

1 reference

12 December 2020

Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.

1 reference

12 December 2020

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000.

1 reference

12 December 2020

Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae

1 reference

12 December 2020

Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers

1 reference

12 December 2020

Gatifloxacin-associated acute hepatitis

1 reference

12 December 2020

Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics.

1 reference

12 December 2020

Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis

1 reference

12 December 2020

Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin

1 reference

12 December 2020

Adverse drug reactions: implications for the development of fluoroquinolones

1 reference

12 December 2020

Pharmacodynamic profiling of levofloxacin and gatifloxacin using Monte Carlo simulation for community-acquired isolates of Streptococcus pneumoniae

1 reference

12 December 2020

Outbreak of Clostridium difficile infection and gatifloxacin use in a long-term care facility

1 reference

12 December 2020

Urinary concentrations and bactericidal activities of newer fluoroquinolones in healthy volunteers

1 reference

12 December 2020

Concentration-dependent changes in the susceptibility and killing of Staphylococcus aureus in an in vitro dynamic model that simulates normal and impaired gatifloxacin elimination.

1 reference

12 December 2020

Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of gatifloxacin against Streptococcus pneumoniae and Staphylococcus aureus in a granulocyte-rich exudate

1 reference

12 December 2020

Oral bioavailability of gatifloxacin in healthy volunteers under fasting and fed conditions

1 reference

12 December 2020

Contribution of the 8-methoxy group to the activity of gatifloxacin against type II topoisomerases of Streptococcus pneumoniae

1 reference

12 December 2020

Multiple-dose pharmacokinetics and excretion balance of gatifloxacin, a new fluoroquinolone antibiotic, following oral administration to healthy Caucasian volunteers

1 reference

12 December 2020

In vitro selection of resistance in haemophilus influenzae by 4 quinolones and 5 beta-lactams.

1 reference

12 December 2020

In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin

1 reference

12 December 2020

Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp.

1 reference

12 December 2020

A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men.

1 reference

12 December 2020

Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance Program

1 reference

12 December 2020

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

1 reference

12 December 2020

Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).

1 reference

12 December 2020

Pharmacodynamics of gatifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model: impact of area under the curve/MIC ratios on eradication

1 reference

12 December 2020

Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000)

1 reference

12 December 2020

Resistance among Streptococcus pneumoniae: Implications for drug selection

1 reference

12 December 2020

Antimicrobial treatment guidelines for acute bacterial rhinosinusitis

1 reference

12 December 2020

A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose

1 reference

12 December 2020

Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000).

1 reference

12 December 2020

10.2165/00003495-200565050-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

1045614131

0 references

1 reference